Brief Summary
This is a randomized, adaptive, open label, multicenter trial to evaluate the safety and efficacy of intraperitoneal (IP) IMNN-001 plus chemotherapy compared to chemotherapy alone.
Protocol Interventions
Drug: Paclitaxel, Drug: Carboplatin, Drug: Olaparib, Drug: Niraparib